Photoshop-based image analysis for the semiautomated assessment of Ki-67-defined proliferative activity in the routine diagnosis of breast cancer

Applied Immunohistochemistry and Molecular Morphology

Volumn 4, Issue 2, 1996, Pages 117-127

  Lehr, Hans Anton ^a   Hansen, Kenneth D ^a   Coltrera, Marc D ^a   Russ, John C ^b   Gown, Allen M ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Image analysis; Proliferative rate; Quantification

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0029888741     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
2. McGuire WL, Clark GM. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 1992;326:1756-61.
3. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast: report of the DNA Cytometry Consensus Conference. Cytometry 1993;14: 482-5.
4. Baak JP, Van-Dop H, Kurver PH, Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer 1985;56:374-82.
5. Hall PA, Levison DA. Review: assessment of cell proliferation in histological material. J Clin Pathol 1990;43:184-92.
6. Woosley JT. Measuring cell proliferation. Arch Pathol Lab Med 1991;115:555-7.
7. Linden MD, Torres FX, Kubus J, Zarbo RJ. Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol 1992;97:S4-13.
8. Sigurdsson H, Baldetorp B, Borg A, et al. Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990; 322:1045-53.
9. Clark GM, Mathieu MC, Owens MA, et al. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol 1992;10:428-32.
10. Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U, von-Kleist S. Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991;67:421-8.
11. Gasparini G, Dal-Fior S, Pozza F, Bevilacqua P. Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma. Breast Cancer Res Treat 1989;14:329-36.
12. Bouzubar N, Walker KJ, Griffiths K, et al. Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 1989;59:943-7.
13. Fonatsch C, Duchrow M, Rieder H, Schluter C, Gerdes J. Assignment of the human Ki-67 gene (MK167) to 10q25-qter. Genomics 1991;11:476-7.
14. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
15. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
16. Ostrowski ML, Chakraborty S, Laucirica R, Brown RW, Greenberg SD. Quantitative image analysis of MIB-1 immunoreactivity: a comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast. Anal Quant Cytol Histol 1995;17:15-24.
17. Lee AK, Wiley B, Loda M, et al. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma. Mod Pathol 1992;5:61-7.
18. Keshgegian AA, Cnaan A. Proliferation markers in breast carcinoma: mitotic figure count, S-phase fraction, proliferating cell nuclear antigen. Ki-67 and MIB-1. Am J Clin Pathol 1995;104:42-9.
19. Kennedy JC, el-Badawy N, DeRose PB, Cohen C. Comparison of cell proliferation in breast carcinoma using image analysis (Ki-67) and flow cytometfic systems. Anal Quant Cytol Histol 1992;14:304-11.
20. Isola J, Helin H, Kallioniemi OP. Immunoelectron-microscopic localization of a proliferation-associated antigen Ki-67 in MCF-7 cells. Histochem J 1990;22:498-506.
21. Dawson AE, Norton JA, Weinberg DS. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 1990; 136:1115-24.
22. Weidner N, Moore DH, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB 1 antibody. Hum Pathol 1994;25:337-42.
23. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168:357-63.
24. Key G, Becker MH, Baron B, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;68:629-36.
25. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB 1. Histopathology 1993;22:355-60.
26. Gown AM, de Wever N, Battifora H. Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1993; 1:256-66.
27. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
28. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol 1984;114:309-21.
29. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
30. Hedley DW. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 1989;10:229-41.
31. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer: a study of 1,409 cases of which 359 have been followed for 15 years. Br J Cancer 1957;9: 359-77.
32. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
33. Bacus S, Flowers JL, Press MF, Bacus JW, McCarty KS Jr. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis [Comments]. Am J Clin Pathol 1988;90:233-9.
34. Vielh P, Chevillard S, Mosseri V, Donatini B, Magdelenat H. Ki67 index and S-phase fraction in human breast carcinomas: comparison and correlations with prognostic factors. Am J Clin Pathol 1990;94:681-6.
35. Zarbo RJ, Visscher DW, Crissman JD. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Anal Quant Cytol Histol 1989;11:391-402.
36. Schwartz BR, Pinkus G, Bacus S, Toder M, Weinberg DS. Cell proliferation in non-Hodgkin's lymphomas: digital image analysis of Ki-67 antibody staining. Am J Pathol 1989; 134:327-36.
37. Pinder SE, Wencyk P, Sibbering DM, et al. Assessment of the new proliferation marker MIB 1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 1995;71:146-9.
38. McGurrin JF, Doria MI, Dawson PJ, Karrison T, Stein H, Franklin WA. Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast. Cancer 1987;59: 1744-50.
39. Gatlin CL, Schaberg ES, Jordan WH, Kuyatt BL, Smith WC. Point counting on the Macintosh: a semiautomated image analysis technique. Anal Quant Cytol Histol 1993;15: 345-50.
40. Kuyatt BL, Reidy CA, Hui KY, Jordan WH. Quantitation of smooth muscle proliferation in cultured aorta: a color image analysis method for the Macintosh. Anal Quant Cytol Histol 1993;15:83-7.
41. Mir R, Johnson H Jr., Mathur R, Wise L, Kahn LB. Ki-67 reactivity in breast carcinoma analyzed by a computer-assisted image system: preliminary results. J Natl Med Assoc 1995;87:554-9.
42. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P. Proliferation index as a prognostic marker in breast cancer. Cancer 1993;71:3926-31.